Tessa Quinn
Pharmaceutical companies have been known to pay doctors billions of dollars for consulting, promotional talks, and meals, among other things. Research has found a correlation between these payments and the drugs that doctors prescribe, with physicians who receive money from drugmakers related to a specific drug prescribing that drug more heavily than doctors without such financial ties. This has led to concerns about the influence of pharmaceutical companies on medical practices and the potential for conflicts of interest. While some defend these payments as a way to share medical information and drive innovation, others argue for stronger action, such as a total ban on drug industry payments to physicians.
| Characteristics | Values |
|---|---|
| Pharmaceutical companies pay doctors for | Consulting, promotional talks, meals, travel, and more |
| Doctors who receive payments from pharmaceutical companies | Prescribe more of those drugs |
| Doctors who do not accept payments from pharmaceutical companies | Prescribe cheaper generic drugs |
| Doctors who accept payments from pharmaceutical companies | Are more inclined to prescribe expensive brand-name drugs |
| Pharmaceutical companies defend payments to doctors by saying | Doctors who interact with a company about a drug may prescribe more of it because they have more information about the appropriate uses for the products |
| Doctors defend accepting payments from pharmaceutical companies by saying | It educates other doctors about important medications |
| Pharmaceutical companies spend | Billions of dollars on speaking fees and expenses to doctors |
| Doctors who accept payments from pharmaceutical companies | Are more likely to prescribe the drugs of those companies |
Explore related products
What You'll Learn
- Doctors prescribe more drugs when incentivised by pharmaceutical companies
- Pharmaceutical companies pay doctors for consulting, promotional talks, and meals
- Doctors defend payments, saying they are important for sharing medical information
- Payments to doctors are sometimes bribes and kickbacks
- Medical societies have unbiased information sources for doctors
Doctors prescribe more drugs when incentivised by pharmaceutical companies
Pharmaceutical companies have been known to pay doctors for consulting, promotional talks, meals, and travel expenses. Research has found that doctors who receive these payments are more likely to prescribe the drugs they are paid to promote. This has been observed across different specialties and drug types, including opioids, urology drugs, oncology treatments, and inflammatory bowel disease treatments. While some argue that these payments are for sharing medical information, others view them as a form of persuasion and bribery.
A ProPublica analysis found that doctors who received payments linked to specific drugs were more likely to prescribe those drugs. This pattern was observed for many widely prescribed brand-name drugs in Medicare, including treatments for diabetes and asthma. Similarly, a study of Medicare data in 2016 revealed that more than one in five doctors who prescribed OxyContin had promotional interactions with the drug's manufacturer, Purdue Pharma.
The practice of pharmaceutical companies paying doctors is not new. As early as 2013, ProPublica reported that one doctor had earned $1 million in just four years by giving promotional talks and consulting for drug companies. Since then, such high earnings have become more common, with more than 700 doctors receiving at least $1 million from drug and medical device companies.
While some physicians defend these payments as a way to educate their peers about important medications, critics argue that they create conflicts of interest and influence how doctors treat their patients. In 2009, the Institute of Medicine urged doctors to end industry conflicts through self-regulation, but little changed. Congress then passed the Physician Payment Sunshine Act in 2010, requiring public disclosure of industry payments. However, this also failed to curb the practice significantly.
The influence of pharmaceutical company payments on doctors' prescribing habits has been confirmed by multiple studies. This has led to concerns about the impact on patients and calls for stronger action, such as a total ban on drug industry payments to physicians. Despite the growing evidence, the medical community has resisted stopping these payments, arguing that they do not harm patients and may even have benefits.
Wi-Fi Access at Kaiser Permanente Hospitals: What You Need to Know
You may want to see also
Explore related products
Pharmaceutical companies pay doctors for consulting, promotional talks, and meals
Pharmaceutical companies have paid doctors billions of dollars for consulting, promotional talks, and meals. Doctors who receive payments linked to specific drugs prescribe those drugs more heavily than doctors without such financial ties. This pattern is consistent for almost all of the most widely prescribed brand-name drugs in Medicare, including treatments for diabetes, asthma, inflammatory bowel disease, and heartburn.
A ProPublica analysis found a relationship between the total value of a doctor's interactions with drug companies and the percentage of brand-name drugs prescribed. For example, doctors who prescribed OxyContin under Medicare in 2016 had often received payments from the manufacturer, Purdue Pharma. Similarly, doctors who received payments from Allergan were found to prescribe Linzess, Alphagan P, Bystolic, Combigan, Lumigan, Namenda, and Restasis more frequently.
While spokespeople for pharmaceutical companies defend these interactions as important for sharing medical information, critics argue that they influence prescribing practices and contribute to high drug prices. In one study, brand-name prescribing for certain classes of drugs was associated with doctors receiving even a single industry-sponsored meal.
The Pharmaceutical Researchers and Manufacturers of America have adopted a voluntary code of conduct stating that occasional meals can be offered as a business courtesy to doctors attending scientific or educational presentations by sales representatives. However, guidelines emphasize that meals should be modest and not part of entertainment or recreational events. Despite this, some doctors have received meals worth thousands of dollars from companies like Pfizer, raising questions about the appropriateness of these practices.
Trump's VA Hospitals: Closure or Care?
You may want to see also
Explore related products
$24.35 $30.99
Doctors defend payments, saying they are important for sharing medical information
Pharmaceutical companies have paid doctors billions of dollars for consulting, promotional talks, meals, and travel expenses. Research has found a correlation between these payments and an increase in the prescription of certain drugs. Doctors who receive money from drugmakers related to a specific drug prescribe that drug more heavily than doctors without such financial ties.
Despite this, doctors defend these payments, arguing that they are important for sharing medical information. Holly Campbell, a spokeswoman for the Pharmaceutical Research and Manufacturers of America, an industry trade group, said it stands to reason that doctors who have interactions with a company about a drug may prescribe more of it “because they have more information about the appropriate uses for the products.” Pharmaceutical companies describe their interactions with physicians as crucial for sharing medical information.
Another defense of pharma payments is that physicians working with the industry drive “innovation.” Physicians’ insights, the argument goes, are essential for new cures, and paid consulting is an appropriate way for physicians to provide them. While this may be true, critics argue that the money is explicitly for the promotion of drugs that are already on the market. For example, in 2017, Genentech paid more than $3 million to physicians to promote Avastin, a chemotherapy drug that has been available since 2004.
Some doctors argue that industry payments do not harm patients and may even have benefits. They claim that the payments provide an opportunity to educate other doctors about important medications. However, critics argue that these payments create conflicts of interest and influence how doctors treat their patients. There are alternative sources, such as medical professional societies, that physicians can use to obtain unbiased information without the potential for influence or bias.
Medicaid Expansion: NCHA's Support for a Healthy North Carolina
You may want to see also
Explore related products
Payments to doctors are sometimes bribes and kickbacks
Pharmaceutical companies have paid doctors billions of dollars for consulting, promotional talks, meals, and more. Doctors who receive money from drugmakers related to a specific drug prescribe that drug more heavily than doctors without such financial ties. This pattern is consistent for almost all of the most widely prescribed brand-name drugs in Medicare, including drugs that treat diabetes, asthma, and more.
The federal anti-kickback statute (AKS) prohibits paying or receiving—or offering or soliciting—any remuneration in return for purchasing, ordering, recommending, or referring a patient to any good or service for which payment may be made under a federal healthcare program. The AKS prohibits both bribes, which come before purchases or referrals, and kickbacks, which come after them. Remuneration is defined broadly and includes payments made directly or indirectly, overtly or covertly, in cash or in kind.
Evidence suggests that many payments that are currently commonplace could be subject to prosecution under the AKS. For example, a 2019 settlement involving Insys Therapeutics provided evidence that the company's speaker program violated the AKS. Speaking events "often did not involve any education or presentations about the drug" or "had no attendees at all," suggesting that these events served as a vehicle to pay bribes to speakers in the disguised form of honoraria.
The empirical evidence that industry payments influence or "skew" physicians' prescribing practices is now strong. Healthcare providers who receive remuneration from a company are more likely to prescribe or order that company's products, which may skew their clinical decision-making in favor of their own and the company's financial interests, rather than the patient's best interests.
Hospital Technician: Steps to Start Your Career
You may want to see also
Explore related products
Medical societies have unbiased information sources for doctors
Pharmaceutical companies have been known to pay doctors for consulting, promotional talks, meals, and other services. Doctors who receive such payments are more likely to prescribe the company's drugs. This has been observed across various drug specialties and types, including opioids, urology drugs, oncology treatments, inflammatory bowel disease treatments, and heartburn medication.
To address this issue and ensure unbiased information sources for doctors, medical societies play a crucial role. These societies, such as the American Heart Association and the Academy of Nutrition and Dietetics, provide credible and unbiased information. They offer guidance and resources to help doctors make informed decisions in the best interests of their patients.
Additionally, federal government agency websites, such as MedlinePlus.gov, are considered reliable sources of health information. These websites provide consumer health information on a wide range of topics and are subject to strict guidelines and oversight. Academic medical institutions and medical research organizations are also trustworthy sources that doctors can refer to.
To further ensure unbiased information, doctors can refer to peer-reviewed scientific literature available on sites like PubMed, Google Scholar, or ScienceDirect. These sites are commonly used by healthcare professionals and provide access to a vast collection of scientific evidence and journals.
When seeking information online, it is essential to exercise good judgment. Websites with dramatic or emotional language and claims that seem too good to be true should be approached with caution. It is advisable to verify the author's background and expertise in the field. Additionally, be wary of commercial websites, as they may prioritize promotional content over unbiased information.
Rehab Services at Kane Regional Hospital: What You Need to Know
You may want to see also
Frequently asked questions
Yes, pharmaceutical companies have been known to pay doctors and hospitals billions of dollars for consulting, promotional talks, and meals.
Pharmaceutical companies give money to hospitals and doctors to promote specific drugs and treatments. Doctors who receive money from drugmakers related to a specific drug prescribe that drug more heavily than doctors without such financial ties.
While it is legal, there is a perception among many physicians that drug company payments are fairly benign. However, drug company whistleblowers and federal prosecutors have explicitly stated that, in some cases, the payments were actually bribes and kickbacks.
